Surgical Treatment Following Failed Medical Treatment of an Interstitial Pregnancy.
interstitial pregnancy
laparoscopy
medical treatment
methotrexate
mifepristone
salpingectomy
Journal
Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208
Informations de publication
Date de publication:
15 Jul 2022
15 Jul 2022
Historique:
received:
22
05
2022
revised:
11
07
2022
accepted:
12
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Interstitial pregnancy (IP) is a type of ectopic pregnancy in which the embryo implants in the interstitial part of the Fallopian tube. It accounts for 2% of all ectopic pregnancies. Signs and symptoms appear later than the other forms of ectopic pregnancies because of its peculiar location. The gold standard for its diagnosis is transvaginal ultrasound. The treatment can be medical or surgical. Medical treatment is based on the systemic or local injection of methotrexate (MTX); a dose of mifepristone can be added with a reported 85-90% success rate. The surgical option is laparoscopic unilateral cornuostomy or unilateral salpingectomy. The therapeutic choice is based on symptoms, serum β-human chorionic gonadotropin (β-hCG) values, and sonographic features. Furthermore, the patient's fertility perspectives should be considered. We report a case of IP in a Caucasian woman of 29 years old, with a previous salpingectomy for ectopic pregnancy medically treated by a double dose of intramuscular MTX 50 mg/m
Identifiants
pubmed: 35888656
pii: medicina58070937
doi: 10.3390/medicina58070937
pmc: PMC9316431
pii:
doi:
Substances chimiques
Chorionic Gonadotropin, beta Subunit, Human
0
Mifepristone
320T6RNW1F
Methotrexate
YL5FZ2Y5U1
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Références
Biomed Res Int. 2020 Aug 01;2020:8703496
pubmed: 32802882
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):640-3
pubmed: 9757964
BJOG. 2016 Dec;123(13):e15-e55
pubmed: 27813249
Obstet Gynecol. 2018 Feb;131(2):e65-e77
pubmed: 29232273
Int J Environ Res Public Health. 2021 Sep 17;18(18):
pubmed: 34574706
Gynecol Obstet Invest. 2003;56(3):148-51
pubmed: 14530615
Obstet Gynecol. 2003 Apr;101(4):778-84
pubmed: 12681886
Am J Obstet Gynecol. 2010 Jan;202(1):15-29
pubmed: 20096253
Hum Reprod Open. 2020 Dec 16;2020(4):hoaa055
pubmed: 33354626
Ultrasound Obstet Gynecol. 2007 Jul;30(1):1-7
pubmed: 17587215
Am J Obstet Gynecol. 1993 Jun;168(6 Pt 1):1759-62; discussion 1762-5
pubmed: 8317518
Front Endocrinol (Lausanne). 2018 Jul 10;9:363
pubmed: 30042729
Aust N Z J Obstet Gynaecol. 2014 Dec;54(6):576-80
pubmed: 25338827
J Gynecol Obstet Hum Reprod. 2020 Apr 20;:101762
pubmed: 32325266
Eur J Obstet Gynecol Reprod Biol. 2012 Nov;165(1):77-81
pubmed: 22771188
J Obstet Gynaecol Can. 2022 Jan;44(1):75-76.e2
pubmed: 34469776
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997